Cancer's true breakthroughs.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 23733210.
- Also identified by DOI 10.1038/nm.3245.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
A new regulatory pathway established last year allows drugs with dramatic early clinical promise to be expedited to the market quicker than ever before. To date, most of these 'breakthrough' designations have gone to cancer agents, raising the prospect of faster access to the latest lifesaving therapies for the estimated 4,500 people newly diagnosed with cancer each day in the US. Elie Dolgin looks at what sets these breakthrough medicines apart.
Medical subject headings
- Antineoplastic Agents
- Drug Discovery